Prana Biotechnology Total Assets 2006-2021 | ATHE

Prana Biotechnology total assets from 2006 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Prana Biotechnology Annual Total Assets
(Millions of US $)
2021 $25
2020 $7
2019 $14
2018 $15
2017 $19
2016 $25
2015 $35
2014 $38
2013 $18
2012 $8
2011 $9
2010 $6
2009 $3
2008 $10
2007 $6
2006 $8
2005 $17
Prana Biotechnology Quarterly Total Assets
(Millions of US $)
2021-06-30 $25
2020-06-30 $7
2019-12-31 $10
2019-06-30 $14
2018-12-31 $10
2018-06-30 $15
2017-12-31 $17
2017-06-30 $19
2016-12-31 $23
2016-06-30 $25
2015-12-31 $28
2015-06-30 $35
2014-12-31 $34
2014-06-30 $38
2013-12-31 $23
2013-06-30 $18
2012-12-31 $13
2012-06-30 $8
2011-12-31 $8
2011-06-30 $9
2010-12-31 $4
2010-06-30 $6
2009-12-31 $8
2009-06-30 $3
2008-12-31 $6
2008-06-30 $10
2007-12-31 $9
2007-06-30 $6
2006-12-31 $9
2006-06-30 $8
2005-12-31 $12
2005-06-30 $17
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.021B $0.003B
Prana Biotechnology was established to commercialize research into Alzheimer's disease and other major age-related degenerative disorders. Their mission is to develop diagnostic and therapeutic drugs to treat the central disease pathways that cause degeneration of the brain as the aging process progresses. Prana's technology has emerged from its researchers at prominent international institutions such as Massachusetts General Hospital at Harvard Medical School and the University of Melbourne.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $122.991B 7.77
Bio-Rad Laboratories (BIO.B) United States $22.443B 45.55
QIAGEN (QGEN) Netherlands $12.439B 21.07
Biohaven Pharmaceutical Holding (BHVN) United States $7.159B 0.00
Arcus Biosciences (RCUS) United States $3.161B 0.00
Emergent Biosolutions (EBS) United States $2.298B 8.26
ADC Therapeutics SA (ADCT) Switzerland $1.545B 0.00
Myovant Sciences (MYOV) United Kingdom $1.443B 0.00
Zymeworks (ZYME) Canada $0.942B 0.00
Ambrx Biopharma (AMAM) United States $0.348B 0.00
SQZ Biotechnologies (SQZ) United States $0.329B 0.00
Enzo Biochem (ENZ) United States $0.163B 16.00